Stay updated with breaking news from Peter Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After some 40 years behind the lens, independent filmmaker Peter Stein stepped out in front of the camera recently to be a contestant on the popular TV quiz show "Jeopardy!"
After some 40 years behind the lens, independent filmmaker Peter Stein stepped out in front of the camera recently to be a contestant on the popular TV quiz show "Jeopardy!"
Biogen Inc noted delayed uptake of its Alzheimer’s drug, Aduhelm, in the US, but said it continues to believe in the treatment’s long-term potential.
Stockholder Peter Stein has filed a class action complaint against Adesto Technologies for violating the Securities Exchange Act of 1934. The complaint
Wednesday, August 4, 2021 Has the Food and Drug Administration (FDA) finally ushered in a new era for the U.S. biosimilar marketplace? Many in the industry are hopeful after the Agency approved its first interchangeable biosimilar, Mylan’s Semglee (insulin glargine) on July 28, 2021. Mylan’s Semglee is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. It is both biosimilar to and interchangeable with Lantus (insulin glargine) meaning it can be substi...